Javascript must be enabled to continue!
In vitro effect of Allopurinol on sickling rate and uric acid level in sickle cell erythrocyte.
View through CrossRef
Objective: Allopurinol is a drug used for the prevention of gout. The in vitro effect of allopurinol on human plasma and erythrocyte of sickle cell haemoglobin(HbSS) were investigated on uric acid level and sickling rate respectively.
Methods: The determination was carried out on samples from 9-25years attending General Hospital Owerri. The plasma uric acid level and sickling rate were determined prior to and after incubation with 100mg standard dose of allopurinol.
Results: The plasma uric acid level was significantly decreased (p<0.05) when compared with the control while sickling rate was significantly increased when compared with the control (p <0.05).The results obtained demonstrated that allopurinol could hasten sickling rate and decrease uric acid level.
Conclusion: These observations suggest that allopurinol concentration in the circulation might induce marked increased in erythrocyte sickling in vivo and reduced the antioxidant ability of uric acid level in sickle cell disease. Consequently, slow recovery from a sickling crisis. This may be detrimental in the management of sickle cell disease
DOI: http://dx.doi.org/10.3126/ajms.v4i3.7992
Asian Journal of Medical Sciences 4(2013) 5-7
Title: In vitro effect of Allopurinol on sickling rate and uric acid level in sickle cell erythrocyte.
Description:
Objective: Allopurinol is a drug used for the prevention of gout.
The in vitro effect of allopurinol on human plasma and erythrocyte of sickle cell haemoglobin(HbSS) were investigated on uric acid level and sickling rate respectively.
Methods: The determination was carried out on samples from 9-25years attending General Hospital Owerri.
The plasma uric acid level and sickling rate were determined prior to and after incubation with 100mg standard dose of allopurinol.
Results: The plasma uric acid level was significantly decreased (p<0.
05) when compared with the control while sickling rate was significantly increased when compared with the control (p <0.
05).
The results obtained demonstrated that allopurinol could hasten sickling rate and decrease uric acid level.
Conclusion: These observations suggest that allopurinol concentration in the circulation might induce marked increased in erythrocyte sickling in vivo and reduced the antioxidant ability of uric acid level in sickle cell disease.
Consequently, slow recovery from a sickling crisis.
This may be detrimental in the management of sickle cell disease
DOI: http://dx.
doi.
org/10.
3126/ajms.
v4i3.
7992
Asian Journal of Medical Sciences 4(2013) 5-7.
Related Results
Bioavailability and pharmacokinetics of intravenously and orally administered allopurinol in healthy Beagles
Bioavailability and pharmacokinetics of intravenously and orally administered allopurinol in healthy Beagles
Abstract
Objectives
To determine bioavailability and pharmacokinetic parameters for allopurinol and its active metabolite, oxypurinol.
Animals
6 healthy, reproductively intact f...
Complex interaction between allopurinol-induced uric acid reduction and glycemic control: a clinical and molecular study
Complex interaction between allopurinol-induced uric acid reduction and glycemic control: a clinical and molecular study
Background: Diabetes mellitus type 2 (DMT2) and hyperuricemia are two prevalent metabolic diseases worldwide, including in Indonesia. In fact, in the Minahasa tribe, the prevalence...
SOME CHARACTERISTICS OF FISH SCALE COLLAGEN/ALLOPURINOL BIOCOMPOSITE
SOME CHARACTERISTICS OF FISH SCALE COLLAGEN/ALLOPURINOL BIOCOMPOSITE
In this work, collagen extracted from fresh-water fish scales has been used as a matrix in the drug delivery polymeric system. Allopurinol has been applied to reduce the concentrat...
Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study
Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study
Objective: To examine whether allopurinol is associated with any alteration in mortality and hospitalisations in patients with chronic heart failure (CHF). This hypothesis is based...
Allosteric Hemoglobin Effector Loaded Erythrocytes Improve the Efficiency of Transfusion to Prevent Sickling.
Allosteric Hemoglobin Effector Loaded Erythrocytes Improve the Efficiency of Transfusion to Prevent Sickling.
Abstract
Sickle cell disease (SCD) is characterised by abnormal haemoglobin S (HbS). Under hypoxic conditions, HbS crystallizes, inducing sickling of red blood cells...
HYPERURICEMIA AND ITS ASSOCIATION WITH HYPERTENSION: RISK FACTORS AND MANAGEMENT
HYPERURICEMIA AND ITS ASSOCIATION WITH HYPERTENSION: RISK FACTORS AND MANAGEMENT
Hyperuricemia is a medical condition that arises due to the increased concentration of uric acid in the body. Worldwide, a surge in the number of hyperuricemia cases has been seen ...
DISTRIBUTION OF SICKLE CELL ALLELE IN ETHNIC SUB-GROUPS OF THARU IN NEPAL
DISTRIBUTION OF SICKLE CELL ALLELE IN ETHNIC SUB-GROUPS OF THARU IN NEPAL
Sickle cell disease has been a major inherited blood disorder in several populations of the world including Tharu tribal communities of Nepal and India. This cross sectional study ...
Independent risk factors associated with Uric Acid Stone disease: A retrospective study
Independent risk factors associated with Uric Acid Stone disease: A retrospective study
Abstract
Objective
To find out the independent risk factors for uric acid stone formation through a retrospective single-center clinical analysis, to provide a scientific ...

